| ACAN | Aggrecan |
| ACV | Articular cartilage vesicle |
| ADAMTS | A disintegrin and metalloproteinase with thrombospondin motifs |
| BMSC | Bone marrow mesenchymal stem cell |
| CCL | Chemokine (C-C motif) ligand |
| COL2A1 | Collagen 2A1 |
| COX-2 | Cyclooxygenase-2 |
| ECM | Extracellular matrix |
| EV | Extracellular vesicle |
| EXO | Exosome |
| FLS | Fibroblast-like synoviocyte |
| GAG | Glycosaminoglycan |
| HA | Hyaluronic acid |
| IFP | Infrapatellar fat pad |
| IL | Interleukin |
| lncRNA | Long non-coding RNA |
| MCP | Monocyte chemoattractant protein |
| miRNA | MicroRNA |
| MMP | Matrix metalloproteinase |
| mPGES-1 | Microsomal prostaglandin E synthase-1 |
| MSC | Mesenchymal stem cell |
| NSAID | Non-steroidal anti-inflammatory drug |
| OA | Osteoarthritis |
| PG | Proteoglycan |
| PGE2 | Prostaglandin E2 |
| PRP | Platelet-rich plasma |
| PUFA | Polyunsaturated fatty acid |
| RA | Rheumatoid arthritis |
| SF | Synovial fluid |
| sGAG | Sulfated glycosaminoglycan |
| SOX9 | SRY-related HMG box 9 |
| SPM | Specialized pro-resolving mediator |
| TGF-β | Transforming growth factor β |
| TNF-α | Tumor necrosis factor α |